Board Meeting5 Nov 2026, 05:56 pm
Asston Pharmaceuticals Board Meeting on Nov 12, 2026
AI Summary
Asston Pharmaceuticals Ltd has announced that a meeting of its Board of Directors is scheduled for November 12, 2026. The primary agenda item is to consider and approve the Unaudited Financial Statements for the Half-Year ended September 30, 2026, along with the accompanying limited review report. Other incidental matters will also be discussed.
Key Highlights
- Board meeting scheduled for November 12, 2026.
- Agenda includes approval of Unaudited Financial Statements.
- Limited review report for H1 FY27 to be considered.
- Focus on financial reporting for the half-year period.
Price Impact
More from APL